Cargando…

The Treatment of Diabetes with Insulin

Detalles Bibliográficos
Autores principales:	Meakins, J., Robson, W., Lambie, C. G., Davies, H. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oliver and Boyd 1923
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332823/

Ejemplares similares

The Treatment of Diabetes Mellitus
por: Lyon, D. Murray, et al.
Publicado: (1921)

Basal Metabolic Rate: Its Determination and Clinical Significance
por: Meakins, Jonathan, et al.
Publicado: (1922)

Diabetes and Pregnancy
por: Lambie, C. G.
Publicado: (1927)

Diabetes and Pregnancy
por: Lambie, C. G.
Publicado: (1927)

Oxygen-Want: Its Causes, Signs, and Treatment
por: Meakins, Jonathan
Publicado: (1922)

Oxygen-Want: Its Causes, Signs, and Treatment
por: Meakins, Jonathan
Publicado: (1922)

An update on absolute and relative indications for dialysis treatment modalities
por: Lambie, Mark, et al.
Publicado: (2023)

PHAGOCYTIC IMMUNITY
por: Meakins, J. C.
Publicado: (1909)

PHAGOCYTIC IMMUNITY IN STREPTOCOCCUS INFECTIONS
por: Meakins, J. C.
Publicado: (1909)

AN EXPERIMENTAL STUDY OF OPSONIC IMMUNITY TO STAPHYLOCOCCUS AUREUS
por: Meakins, J. C.
Publicado: (1910)

Functional groups : characteristics and interconversions /
por: Meakins, G. Denis
Publicado: (1996)

The Influence of Edinburgh on M'Gill University and American Medicine
por: Meakins, Jonathan
Publicado: (1920)

DATA CONCERNING THE ETIOLOGY AND PATHOLOGY OF HEMORRHAGIC NECROSIS OF THE PANCREAS (ACUTE HEMORRHAGIC PANCREATITIS)
por: Opie, Eugene L., et al.
Publicado: (1909)

Diabetes and Insulin Treatment in Bengal
por: Bose, J. P.
Publicado: (1925)

Diabetes and Insulin Treatment in Bengal
por: Ghosal, Lal Mohan
Publicado: (1925)

Observations on the Carbonic Anhydrase of the Blood in Anæmia and in Other Pathological Conditions
por: Lambie, C. G.
Publicado: (1938)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
por: Rosenstock, J., et al.
Publicado: (2008)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
por: Jones, Angus G, et al.
Publicado: (2012)

Patterns of Improvement in Resection of Hepatocellular Carcinoma in Cirrhotic Patients: Results of a Non Drainage Policy
por: Smadja, C., et al.
Publicado: (1989)

Insulin Receptor Substrate 2 Expression and Involvement in Neuronal Insulin Resistance in Diabetic Neuropathy
por: Grote, C. W., et al.
Publicado: (2011)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
por: Davies, M. J., et al.
Publicado: (2016)

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
por: Hemkens, L. G., et al.
Publicado: (2009)

Reliability of the Shoulder Symptom Modification Procedure and association of within-session and between-session changes with functional outcomes
por: Meakins, Adam, et al.
Publicado: (2018)

Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes
por: Bowering, K., et al.
Publicado: (2018)

Determinants of insulin treatment satisfaction among type 2 diabetic older adults
por: Zaouali, F., et al.
Publicado: (2022)

Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial
por: Davies, M J, et al.
Publicado: (2014)

Stem Cells in the Treatment of Insulin-Dependent Diabetes Mellitus
por: Borisov, M. A., et al.
Publicado: (2016)

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons
por: van Hoek, M., et al.
Publicado: (2011)

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
por: Davies, M J, et al.
Publicado: (2009)

Diabetes, insulin treatment, and cancer risk: what is the evidence?
por: Azar, Madona, et al.
Publicado: (2010)

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes
por: Home, P D, et al.
Publicado: (2015)

Insulin Treatment Reduces Susceptibility to Atrial Fibrillation in Type 1 Diabetic Mice
por: Maria, Zahra, et al.
Publicado: (2020)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
por: Rodbard, H W, et al.
Publicado: (2013)

A Role for Insulin in Diabetic Neuropathy
por: Grote, Caleb W., et al.
Publicado: (2016)

On the Relation between the Hormones of the Anterior Lobe of the Pituitary and Clinical Syndromes
por: Lambie, C. G., et al.
Publicado: (1931)

Place of technosphere inhaled insulin in treatment of diabetes
por: Mikhail, Nasser
Publicado: (2016)

Insulin Glargine in the Treatment of Type 1 and Type 2 Diabetes
por: Barnett, Anthony H
Publicado: (2006)

Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment
por: Cai, Xiaoling, et al.
Publicado: (2012)

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors
por: Bronsveld, Heleen K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j19hvvb1jvrqm4gm5droovuvm7